The primary objective of this clinical trial is to evaluate the acceptability, tolerability, and efficacy of the ID-Cap-M in a healthy population. The ID-Cap is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.